INSITU TECHNOLOGIES (PVT) LIMITED

Overview

A long-term manufacturing initiative connecting InSitu’s global cardiovascular device experience with Pakistan’s healthcare and industrial priorities.

Company Profile

InSitu Technologies® Inc. is a privately held medical device company specializing in covered stents, drug eluting stents, balloon catheters and other cardiovascular products. The unique design and ingenuity of our products is the direct result of collaboration with physicians from around the world.

We are dedicated to providing state-of-the-art minimally invasive devices that are carefully engineered with patented and proprietary designs. Our covered stents are known worldwide and trusted by physicians as a preferred choice.

Headquartered in Eagan, Minnesota, USA, InSitu Technologies operates with distributors in over 50 countries across multiple continents.

Mission Statement

InSitu Technologies® Inc. is devoted to extending the lives of our patients. We strive to meet the needs of our customers by engineering minimally invasive medical devices of the highest quality.

Quality Policy

InSitu Technologies® Inc. is committed to delivering safe and effective designs and manufacturing solutions for intravascular medical devices that conform to regulatory and customer requirements.

We achieve this through strict regulatory compliance, dedicated employee focus on quality, and continuous improvement of our quality management system and processes.

OUR FOUNDATION

Established experience, transferred with purpose.

InSitu Technologies Inc. was founded in 1995 in St. Paul, Minnesota, USA, by Mr. Amjad Ahmad. The company has developed cardiovascular and peripheral device expertise and relationships across more than 40 countries.

InSitu Technologies (PVT) Limited brings that engineering heritage to a manufacturing initiative in Rawalpindi as a subsidiary of InSitu Technologies Inc., USA.

THE NATIONAL OPPORTUNITY

Building resilience in a market dependent on imports.

More than 400,000 PCI procedures are performed each year in Pakistan. The planned facility is intended to reduce reliance on imported stents while building domestic technical capability, skilled employment, and a pathway toward exports.

The initiative will draw on InSitu’s established distributor network as export capability develops.